Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian Men

This study has been completed.
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Susanne Kruger Kjaer, Danish Cancer Society Identifier:
First received: June 30, 2009
Last updated: August 7, 2015
Last verified: August 2015
The purpose of this study is to determine the prevalence and type distribution of genital human papillomavirus (HPV) infection in Tanzanian men.

Human Papillomavirus Infection

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Prevalence and Type Distribution of Genital Human Papillomavirus (HPV) in Tanzanian Men

Resource links provided by NLM:

Further study details as provided by Susanne Kruger Kjaer, Danish Cancer Society:

Primary Outcome Measures:
  • HPV infection [ Time Frame: At enrollment ]

Secondary Outcome Measures:
  • HIV infection [ Time Frame: At enrollment ]

Biospecimen Retention:   Samples With DNA
cell scrapes from penis

Enrollment: 1933
Study Start Date: March 2009
Study Completion Date: December 2009
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Human papillomavirus
Tanzanian men with HPV and Tanzanian men without

  Show Detailed Description


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Tanzanian men from an urban setting (Dar es Sallam)(factories, University, college)and men from an rural setting (Muhesa, Mwanga, Bagamoyo)

Inclusion Criteria:

  • men who are able to understand the information about the study (in writing or oral)

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00932009

Inst. of Cancer Epidemiology, Danish Cancer Society
Copenhagen, Denmark, DK-2100
Sponsors and Collaborators
Danish Cancer Society
Merck Sharp & Dohme Corp.
Principal Investigator: Susanne K. Kjaer, Professor MD Inst. of Cancer Epidemiology,Danish Cancer Society
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Susanne Kruger Kjaer, Professor, Danish Cancer Society Identifier: NCT00932009     History of Changes
Other Study ID Numbers: HPV IISP #36113
Study First Received: June 30, 2009
Last Updated: August 7, 2015

Keywords provided by Susanne Kruger Kjaer, Danish Cancer Society:
Human papillomavirus infection
Tanzanian men

Additional relevant MeSH terms:
Papillomavirus Infections
DNA Virus Infections
Virus Diseases
Tumor Virus Infections processed this record on May 25, 2017